»Meet our Beckman Scholars

Chloe Castanon '25

Benjamin Janda '23

Emma Kocik '22

Molly Niswender '26
Niswender is working with Assistant Professor Cecilia Zurita Lopez to characterize PRMT7 Substrate Methylation in Triple Negative Breast Cancer Metastasis. Triple-negative breast cancer is an aggressive subtype with limited treatment options and poor prognosis, particularly when metastasis occurs. Protein arginine methyltransferase 7 (PRMT7) has been found to be overexpressed in metastatic breast cancer, while tumor suppressor p53 is often functionally impaired in these cases. Niswender is investigating the potential role of PRMT7 in directly methylating p53 at specific arginine residues, thereby altering its transcriptional activity and promoting cancer progression. Using a combination of in vitro methylation assays, mass spectrometry, and transcriptional analysis via qPCR, Niswender aims to determine whether PRMT7-mediated monomethylation impacts p53’s regulation of downstream targets such as p21. The work could reveal a novel mechanism of triple-negative breast cancer metastasis and identify PRMT7 as a viable therapeutic target.

Kevin Nguyen '24

Paul Rosa '24

Katie Sanders '26

Ishaan Shah '23

Lea-Sophie Vetter '26

